AEON Biopharma, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2026-03-31

Reported

2026-05-14

Disclosure lag

44 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	AEON Biopharma, Inc.
Source	SEC EDGAR ↗
News section	Unclassified
Source identifier	companyfacts/CIK0001837607/2026-07-26
Source-linked related entities	None recorded
Event ID	#27411

Related recorded events

same canonical or source-linked entity relations

Reported	Type	Event	Source
2026-08-21	Insider purchase	Event #911187	SEC EDGAR
2026-08-12	New filing	Event #674263	SEC EDGAR
2026-08-03	New filing	Event #279160	SEC EDGAR
2026-07-23	New filing	Event #19563	SEC EDGAR
2026-07-15	New filing	Event #21939	SEC EDGAR
2026-07-15	New filing	Event #21935	SEC EDGAR
2026-07-09	New filing	Event #23399	SEC EDGAR
2026-07-08	New filing	Event #23682	SEC EDGAR

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001837607-26-000042",
  "canonical_covered": 10,
  "canonical_total": 12,
  "fiscal_period": "Q1",
  "fiscal_year": 2026,
  "form": "10-Q",
  "mapped_tag_share": 0.05529953917050691,
  "metrics": {
    "cash_and_equivalents": 6243000,
    "earnings_per_share_basic": -0.29,
    "earnings_per_share_diluted": -0.29,
    "net_income": -11793000,
    "operating_cash_flow": -2636000,
    "operating_income": -5933000,
    "shareholders_equity": -16752000,
    "shares_outstanding": 25303058,
    "total_assets": 8630000,
    "total_liabilities": 25382000
  },
  "metrics_reported": 10,
  "period_end": "2026-03-31"
}

Evidence-based analysis

facts, provenance and explicit model coverage

Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.

Dimension	Status / value	Method or boundary
What happened	not_covered	The source record has no short title or summary.
When	source_backed · reported 2026-05-14	Occurred 2026-03-31. Source-record timestamps; no timezone or event time is inferred.
Affected entities	resolved · AEON Biopharma, Inc. · 0 related	Canonical primary entity and stored related_entity_ids only.
Event classification	financial · financial.report	canonical event type plus source-provided category; no sentiment or impact is inferred
Entity linking	resolved	Canonical entity resolved during ingestion
Deduplication	applied	unique source event key at ingestion
Source trust	high · terms allowed	Source registry metadata
Sentiment	not_covered	No sentiment model output is published for this record.
Market reaction	not_covered	Requires licensed quote, candle and volume observations for the affected instrument.
Historical analogs	not_covered	Requires an audited event-cluster corpus and matching methodology.
Impact mechanism	not_covered	No causal market-impact model is published for this record.
Related risks	not_covered	Risk implications require an audited instrument/entity exposure model.
Instrument linkage	not_covered	No instrument relation is inferred from an entity event; licensed instrument mapping is required.

Source: SEC EDGAR · as of 2026-05-14T00:00:00Z